VanEck U.S. Domestic Moats: Buy Buy Baby (Contd..) It’s been a wild ride for pharmaceutical and biotech companies since last year’s U.S. presidential election, but Morningstar’s economic moat and valuation research within both industries benefited the U.S. Moat Index as several of the top drivers of performance came from within those industries. Materials firm Compass […]
PLGAX had a great year in 2015, as its risk-adjusted returns, the consistency of returns, and alpha ranked it as the second-best fund in our peer group.
Investors and players in the industrial sector are keenly interested in the US durable goods report. Industrial sector firms rose on Wall Street July 29.
Covanta (CVA) has underperformed the broader market since the beginning of 2015. SPY has risen 3.4% through June 24, while CVA has remained steady, posting marginal 0.2% returns.
Covanta Holding’s (CVA) revenues increased marginally in fiscal 2014, but cost of sales saw a substantial uptick that year. Operating expenses increased $130 million, or 9.2%.
